Anti-cytotoxic T-lymphocyte antigen-4 (CTLA 4) probody BMS-986249 ± nivolumab (NIVO) in patients (pts) with advanced cancers: Updated phase I results

This article has no abstract
Epistemonikos ID: 509892433fd39beda646c330581fbe29a6a746c9
First added on: Feb 15, 2025